Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 16/20 | 0.77 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | MITF | O75030 | 1/20 | 0.61 |
| ▸ | XBP1 | P17861 | 1/20 | 0.61 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.61 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | KDR | P35968 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL845881 | 0.93 | TRPV1 (0.78) | TRPV1NPC1RAB9AKDM4EMITF | |
| SCHEMBL846453 | 0.87 | TRPV1 (1.00) | TRPV1NPC1RAB9AKDM4EMITF | |
| SCHEMBL846181 | 0.85 | TRPV1 (0.80) | TRPV1NPC1RAB9AKDM4EMITF | |
| SCHEMBL845924 | 0.82 | TRPV1 (0.79) | TRPV1NPC1RAB9AKDM4EMITF | |
| SCHEMBL846097 | 0.81 | TRPV1 (0.81) | TRPV1NPC1RAB9AKDM4EMITF | |
| SCHEMBL845760 | 0.81 | TRPV1 (1.00) | TRPV1NPC1RAB9AKDM4EMITF | |
| SCHEMBL844349 | 0.80 | TRPV1 (0.77) | TRPV1NPC1RAB9AKDM4EMITF | |
| SCHEMBL846823 | 0.80 | TRPV1 (1.00) | TRPV1NPC1RAB9AKDM4EMITF | |
| SCHEMBL846635 | 0.80 | TRPV1 (0.63) | TRPV1NPC1RAB9AKDM4EMITF | |
| SCHEMBL846553 | 0.80 | TRPV1 (0.68) | TRPV1NPC1RAB9AKDM4EMITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1603883-B1 | QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR | JANSSEN PHARMACEUTICA NV (BE) | 2012-03-28 | — | — | EP | disclosed |
| EP-2308848-A1 | Quinoline-derived amide modulators of vanilloid VR1 receptor | Janssen Pharmaceutica NV (BE) | 2011-04-13 | — | — | EP | disclosed |